Immunotoxicology has historically relied on in vivo animal models to assess the potential adverse effects of chemicals, ...
TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New Approach Methodologies Developer Coalition (NAMs-DC), a precompetitive, ...
The New Approach Methodologies (NAMs) initiative aims to replace the use of animal models when testing the safety and efficacy of therapeutics and drugs by promoting the development and adoption of ...
The International Society for Stem Cell Research (ISSCR) Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development has submitted comments to the U.S. Food and Drug Administration ...